Lv3
250 积分 2022-10-30 加入
SOHO State of the Art Updates and Next Questions | Venetoclax + Obinutuzumab Therapy in Chronic Lymphocytic Leukemia
3个月前
已完结
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML
5个月前
已完结
Development of a scoring system for predicting primary resistance to venetoclax plus hypomethylating agents (HMAs) in acute myeloid leukemia patients
5个月前
已完结
Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: validation of a risk score in a chemotherapy plus ATRA cohort from an international consortium
7个月前
已完结
Acute Promyelocytic Leukemia: Long-Term Outcomes from the HARMONY Project
7个月前
已关闭
Acute Promyelocytic Leukemia: Long-Term Outcomes from the HARMONY Project
7个月前
已关闭
Acute Promyelocytic Leukemia: Long-Term Outcomes from the HARMONY Project
7个月前
已关闭
Acute Promyelocytic Leukemia: Long-Term Outcomes from the HARMONY Project
7个月前
已关闭
Clinical and biological advances of critical complications in acute myeloid leukemia
8个月前
已完结
Clinical and biological advances of critical complications in acute myeloid leukemia
8个月前
已关闭
皖公网安备34019202002308
